COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
LR Health & Beauty SE reports on business development in the third quarter of 2025
LR Health & Beauty SE reports on business development in Q3 2025, with sales of EUR 66.0 million and EBITDA of EUR 2.9 million. Focus on fragrance segment, capital structure, and earnings guidance revision -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: LR Health & Beauty SE: BREACH OF LEVERAGE COVENANT / NO INTEREST PAYMENT / STANDSTILL NEGOTIATIONS WITH AN AD HOC GROUP OF BONDHOLDERS / APPOINTMENT OF A REPUTABLE FIRM TO SUPPORT ...
LR Health & Beauty SE announces breach of leverage covenant, no interest payment, and standstill negotiations with bondholders. Firm appointed to support financial restructuring
